Skip to main content
Log in

Does Single Use of an Autologous Transfusion System in TKA Reduce the Need for Allogenic Blood?: A Prospective Randomized Trial

  • Clinical Research
  • Published:
Clinical Orthopaedics and Related Research®

Abstract

Background

Mechanical autotransfusion systems for washed shed blood (WSB) were introduced to reduce the need for postoperative allogenic blood transfusions (ABTs). Although some authors have postulated decreased requirements for ABT by using autologous retransfusion devices, other trials, mostly evaluating retransfusion devices for unwashed shed blood (USB), verified a small or no benefit in reducing the need for postoperative ABT. Because of these contradictory findings it is still unclear whether autologous retransfusion systems for WSB can reduce transfusion requirements.

Questions/purposes

We therefore asked whether one such autologous transfusion system for WSB can reduce the requirements for postoperative ABT.

Methods

In a prospective, randomized, controlled study, we enrolled 151 patients undergoing TKA. In Group A (n = 76 patients), the autotransfusion system was used for a total of 6 hours (intraoperatively and postoperatively) and the WSB was retransfused after processing. In Control Group B (n = 75 patients), a regular drain without suction was used. We used signs of anemia and/or a hemoglobin value less than 8 g/dL as indications for transfusion. If necessary, we administered one or two units of allogenic blood.

Results

Twenty-three patients (33%) in Group A, who received an average of 283 mL (range, 160–406 mL) of salvaged blood, needed a mean of 2.1 units of allogenic blood, compared with 23 patients (33%) in Control Group B who needed a mean of 2.1 units of allogenic blood.

Conclusions

We found the use of an autotransfusion system did not reduce the rate of postoperative ABTs.

Level of Evidence

Level II, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Amin A, Watson A, Mangwani J, Nawabi D, Ahluwalia R, Loeffler M. A prospective randomised controlled trial of autologous retransfusion in total knee replacement. J Bone Joint Surg Br. 2008;90:451–454.

    Article  PubMed  CAS  Google Scholar 

  2. Biedler AE, Schneider SO, Seyfert U, Rensing H, Grenner S, Girndt M, Bauer I, Bauer M. Impact of alloantigens and storage-associated factors on stimulated cytokine response in an in vitro model of blood transfusion. Anesthesiology. 2002;97:1102–1109.

    Article  PubMed  CAS  Google Scholar 

  3. Buchta C, Hanslik-Schnabel B, Weigl R, List J, Körmöczi GF, Macher M, Heinzl H, Höcker P, Wanivenhaus A, Kurz M. Quality of drainage blood: survival of red cells after re-transfusion and content of free hemoglobin and potassium. Int J Surg. 2005;3:250–253.

    Article  PubMed  Google Scholar 

  4. Clark CR. Perioperative blood management in total hip arthroplasty. Instr Course Lect. 2009;58:167–172.

    PubMed  Google Scholar 

  5. Clark CR, Spratt KF, Blondin M, Craig S, Fink L. Perioperative autotransfusion in total hip and knee arthroplasty. J Arthroplasty. 2006;21:23–35.

    Article  PubMed  Google Scholar 

  6. Colwell CW Jr, Beutler E, West C, Hardwick ME, Morris BA. Erythrocyte viability in blood salvaged during total joint arthroplasty with cement. J Bone Joint Surg Am. 2002;84:23–25.

    Article  PubMed  Google Scholar 

  7. del Trujillo MM, Carrero A, Muñoz M. The utility of the perioperative autologous transfusion system OrthoPAT® in total hip replacement surgery: a prospective study. Arch Orthop Trauma Surg. 2008;128:1031–1038.

    Article  PubMed  Google Scholar 

  8. Garvin KL, Feschuk CA, Sekundiak TD, Lyden ER. Blood salvage and allogenic transfusion needs in revision hip arthroplasty. Clin Orthop Relat Res. 2005;441:205–209.

    Article  PubMed  Google Scholar 

  9. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion. 2007;47:1468–1480.

    Article  PubMed  Google Scholar 

  10. Goodnough LT. Risks of blood transfusion. Anesthesiol Clin North America. 2005;23:241–252, v.

    Google Scholar 

  11. Grosvenor D, Goyal V, Goodman S. Efficacy of postoperative blood salvage following total hip arthroplasty in patients with and without deposited autologous units. J Bone Joint Surg Am. 2000;82:951–954.

    PubMed  Google Scholar 

  12. Hansen E, Pawlik M. Reasons against the retransfusion of unwashed wound blood. Transfusion. 2004;44:45S–53S.

    Article  PubMed  Google Scholar 

  13. Harling DW. Consistency of ASA grading. Anaesthesia. 1995;50:659.

    PubMed  CAS  Google Scholar 

  14. Hazarika S, Bhattacharya R, Bhavikatti M, Dawson M. A comparison of post-op haemoglobin levels and allogeneic blood transfusion rates following total knee arthroplasty without drainage or with reinfusion drains. Acta Orthop Belg. 2010;76:74–78.

    PubMed  Google Scholar 

  15. Hendrych J. [Use of post-operative drainage and auto-transfusion sets in total knee arthroplasty] [in Czech]. Acta Chir Orthop Traumatol Cech. 2006;73:34–38.

    PubMed  CAS  Google Scholar 

  16. Jones HW, Savage L, White C, Goddard R, Lumley H, Kashif F, Gurusany K. Postoperative autologous blood salvage drains are they useful in primary uncemented hip and knee arthroplasty? A prospective study of 186 cases. Acta Orthop Belg. 2004;70:466–473.

    PubMed  Google Scholar 

  17. Lakshmanan P, Purushothaman B, Sharma A. Impact of reinfusion drains on hemoglobin level in total knee arthroplasty. Am J Orthop (Belle Mead NJ). 2010;39:70–74.

    Google Scholar 

  18. Martin A, von Strempel A. Transfusion of autologous blood from reinfusion systems in total knee arthroplasty. Int Orthop. 2006;30:541–544.

    Article  PubMed  CAS  Google Scholar 

  19. Mauerhan DR, Nussman D, Mokris JG, Beaver WB. Effect of postoperative reinfusion systems on hemoglobin levels in primary total hip and total knee arthroplasties: a prospective randomized study. J Arthroplasty. 1993;8:523–527.

    Article  PubMed  CAS  Google Scholar 

  20. Moonen AF, Knoors NT, van Os JJ, Verburg AD, Pilot P. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion. 2007;47:379–384.

    Article  PubMed  Google Scholar 

  21. Moonen AF, Neal TD, Pilot P. Peri-operative blood management in elective orthopaedic surgery: a critical review of the literature. Injury. 2006;37:S11–16.

    Article  PubMed  Google Scholar 

  22. Muñoz M, Ariza D, Garcerán MJ, Gómez A, Campos A. Benefits of postoperative shed blood reinfusion in patients undergoing unilateral total knee replacement. Arch Orthop Trauma Surg. 2005;125:385–389.

    Article  PubMed  Google Scholar 

  23. Muñoz M, García-Vallejo JJ, Ruiz MD, Romero R, Olalla E, Sebastián C. Transfusion of post-operative shed blood: laboratory characteristics and clinical utility. Eur Spine J. 2004;13(suppl 1):S107–113.

    Article  PubMed  Google Scholar 

  24. Muñoz M, Kühlmorgen B, Ariza D, Haro E, Marroquí A, Ramirez G. Which patients are more likely to benefit from postoperative shed blood salvage after unilateral total knee replacement? An analysis of 581 consecutive procedures. Vox Sang. 2007;92:136–141.

    Article  PubMed  Google Scholar 

  25. Muñoz Gómez M, Ariza Villanueva D, Romero Ruiz A, Muñoz Morán E, Prat Arrojo I, Gómez Luque A. [Evaluation of the OrthoPAT autologous transfusion system by experimental models simulating intra- and postoperative blood salvage][in Spanish]. Rev Esp Anestesiol Reanim. 2005;52:321–327.

  26. Newman JH, Bowers M, Murphy J. The clinical advantages of autologous transfusion: a randomized, controlled study after knee replacement. J Bone Joint Surg Br. 1997;79:630–632.

    Article  PubMed  CAS  Google Scholar 

  27. Pierson JL, Hannon TJ, Earles DR. A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone Joint Surg Am. 2004;86:1512–1518.

    PubMed  Google Scholar 

  28. Pola E, Papaleo P, Santoliquido A, Gasparini G, Aulisa L, De Santis E. Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty. J Bone Joint Surg Am. 2004;86:57–61.

    PubMed  Google Scholar 

  29. Ralley FE, Berta D, Binns V, Howard J, Naudie DD. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res. 2010;468:1905–1911.

    Article  PubMed  Google Scholar 

  30. Reize P, Endele D, Rudert M, Wülker N. [Postoperative autologous transfusion from blood drainage after total hip joint arthroplasty: how much value is really there?] [in German]. Z Orthop Ihre Grenzgeb. 2006;144:400–404.

    Article  PubMed  CAS  Google Scholar 

  31. Rollo VJ, Hozack WJ, Rothman RH, Chao W, Eng KO. Prospective randomized evaluation of blood salvage techniques for primary total hip arthroplasty. J Arthroplasty. 1995;10:532–539.

    Article  PubMed  CAS  Google Scholar 

  32. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL; OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43:459–469.

    Article  PubMed  Google Scholar 

  33. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections: the Retrovirus Epidemiology Donor Study. N Engl J Med. 1996;334:1685–1690.

    Article  PubMed  CAS  Google Scholar 

  34. Smith LK, Williams DH, Langkamer VG. Post-operative blood salvage with autologous retransfusion in primary total hip replacement. J Bone Joint Surg Br. 2007;89:1092–1097.

    Article  PubMed  CAS  Google Scholar 

  35. Southern EP, Huo MH, Mehta JR, Keggi KJ. Unwashed wound drainage blood: what are we giving our patients? Clin Orthop Relat Res. 1995;320:235–246.

    PubMed  Google Scholar 

  36. Steinberg EL, Ben-Galim P, Yaniv Y, Dekel S, Menahem A. Comparative analysis of the benefits of autotransfusion of blood by a shed blood collector after total knee replacement. Arch Orthop Trauma Surg. 2004;124:114–118.

    Article  PubMed  Google Scholar 

  37. Strümper D, Weber EW, Gielen-Wijffels S, Van Drumpt R, Bulstra S, Slappendel R, Durieux ME, Marcus MA. Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty. Transfusion. 2004;44:1567–1571.

    Article  PubMed  Google Scholar 

  38. Tobias JD. Strategies for minimizing blood loss in orthopedic surgery. Semin Hematol. 2004;41(1 suppl 1):145–156.

    Article  PubMed  Google Scholar 

  39. Warner C. The use of the orthopaedic perioperative autotransfusion (OrthoPAT) system in total joint replacement surgery. Orthop Nurs. 2001;20:29–32.

    Article  PubMed  CAS  Google Scholar 

  40. Waters JH, Dyga RM. Postoperative blood salvage: outside the controlled world of the blood bank. Transfusion. 2007;47:362–365.

    Article  PubMed  Google Scholar 

  41. Woolson ST, Wall WW. Autologous blood transfusion after total knee arthroplasty: a randomized, prospective study comparing predonated and postoperative salvage blood. J Arthroplasty. 2003;18:243–249.

    Article  PubMed  Google Scholar 

  42. Zacharopoulos A, Apostolopoulos A, Kyriakidis A. The effectiveness of reinfusion after total knee replacement: a prospective randomised controlled study. Int Orthop. 2007;31:303–308.

    Article  PubMed  CAS  Google Scholar 

  43. Zarin J, Grosvenor D, Schurman D, Goodman S. Efficacy of intraoperative blood collection and reinfusion in revision total hip arthroplasty. J Bone Joint Surg Am. 2003;85:2147–2151.

    PubMed  Google Scholar 

Download references

Acknowledgments

We thank R. Germann Assoc. Prof. MD and G. Pfanner MD, Department of Anesthesia, University Teaching Hospital Feldkirch, Medical University of Innsbruck, Feldkirch, Austria, and A. von Strempel Assoc. Prof., MD, DEng, Department of Orthopaedic Surgery, University Teaching Hospital, Medical University of Innsbruck, Feldkirch, Austria, for scientific assistance and editorial review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arno Martin MD, MSc.

Additional information

Each author certifies that he or she, or a member of his or her immediate family, has no funding or commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research editors and board members are on file with the publication and can be viewed on request.

Clinical Orthopaedics and Related Research neither advocates nor endorses the use of any treatment, drug, or device. Readers are encouraged to always seek additional information, including FDA approval status, of any drug or device before clinical use.

Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.

This work was performed at Department of Orthopaedic Surgery, Academic Teaching Hospital, Medical University of Innsbruck, Feldkirch, Austria.

About this article

Cite this article

Cip, J., Widemschek, M., Benesch, T. et al. Does Single Use of an Autologous Transfusion System in TKA Reduce the Need for Allogenic Blood?: A Prospective Randomized Trial. Clin Orthop Relat Res 471, 1319–1325 (2013). https://doi.org/10.1007/s11999-012-2729-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-012-2729-1

Keywords

Navigation